As of 2024-12-11, the EV/EBITDA ratio of Affimed NV (AFMD) is -0.68. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AFMD's latest enterprise value is 42.19 mil USD. AFMD's TTM EBITDA according to its financial statements is -61.80 mil USD. Dividing these 2 quantities gives us the above AFMD EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 4.0x - 11.9x | 8.0x |
| Forward P/E multiples | 3.5x - 9.9x | 6.7x |
| Fair Price | (17.36) - (43.00) | (31.79) |
| Upside | -826.4% - -1899.3% | -1430.2% |
| Date | EV/EBITDA |
| 2024-12-04 | -0.67 |
| 2024-12-03 | -0.67 |
| 2024-12-02 | -0.74 |
| 2024-11-29 | -0.75 |
| 2024-11-27 | -0.75 |
| 2024-11-26 | -0.76 |
| 2024-11-25 | -0.79 |
| 2024-11-22 | -0.70 |
| 2024-11-21 | -0.70 |
| 2024-11-20 | -0.72 |
| 2024-11-19 | -0.79 |
| 2024-11-18 | -0.83 |
| 2024-11-15 | -0.90 |
| 2024-11-14 | -0.94 |
| 2024-11-13 | -0.96 |
| 2024-11-12 | -0.97 |
| 2024-11-11 | -0.98 |
| 2024-11-08 | -0.99 |
| 2024-11-07 | -0.98 |
| 2024-11-06 | -0.92 |
| 2024-11-05 | -0.94 |
| 2024-11-04 | -0.85 |
| 2024-11-01 | -0.85 |
| 2024-10-31 | -0.84 |
| 2024-10-30 | -0.87 |
| 2024-10-29 | -0.87 |
| 2024-10-28 | -0.87 |
| 2024-10-25 | -0.86 |
| 2024-10-24 | -0.86 |
| 2024-10-23 | -0.88 |
| 2024-10-22 | -0.90 |
| 2024-10-21 | -0.88 |
| 2024-10-18 | -0.92 |
| 2024-10-17 | -0.86 |
| 2024-10-16 | -0.87 |
| 2024-10-15 | -0.82 |
| 2024-10-14 | -0.82 |
| 2024-10-11 | -0.79 |
| 2024-10-10 | -0.79 |
| 2024-10-09 | -0.81 |
| 2024-10-08 | -0.82 |
| 2024-10-07 | -0.83 |
| 2024-10-04 | -0.84 |
| 2024-10-03 | -0.85 |
| 2024-10-02 | -0.86 |
| 2024-10-01 | -0.86 |
| 2024-09-30 | -0.87 |
| 2024-09-27 | -0.87 |
| 2024-09-26 | -0.86 |
| 2024-09-25 | -0.86 |